secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0000947871-24-000587
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35B (~US$985M)
-----------------------------------------------------------------------

- Cash purchase price of ~C$1.35B (US$985M) including net debt, funded with cash and debt.
- LifeLabs generates ~C$970M (US$710M) annual revenue; deal slightly dilutive to GAAP EPS but accretive to adjusted EPS in first 12 months.
- LifeLabs will retain its brand, Canadian HQ, and management; Quest to provide expertise and resources.
- Closing expected by end of 2024, subject to Canadian regulatory approvals and key customer consents.
- LifeLabs has >6,500 employees and is a leading Canadian community lab; existing reference relationship with Quest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787124000587/0000947871-24-000587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787124000587/ss3544770_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-24-000587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer